Photodynamic therapy in non‐subfoveal choroidal neovascularization secondary to pathological myopia: 1‐year outcome

Ítems similars

• Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia
  per: Yamamoto, Izumi, et al.
  Publicat: (2007)
• Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes
  per: Hussain, Nazimul, et al.
  Publicat: (2008)
• Intravitreal aflibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks
  per: Esen, Ebru, et al.
  Publicat: (2015)
• Angiofluorographic Characteristics of Choroidal Neovascularization associated with Pathologic Myopia
  per: Tomi, Anca, et al.
  Publicat: (2020)
• Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
  per: Rishi, Pukhraj, et al.
  Publicat: (2011)